House Concurrent Resolution No. by Representative Chassion urges the Louisiana Department of Health to conduct a comprehensive review of the implementation of existing laws and guidance regarding pregnancy-related emergency medications in various healthcare settings, including hospitals, acute care facilities, urgent care centers, and retail pharmacies. This review is prompted by the classification of certain medications as Schedule IV controlled substances under Louisiana law, which imposes specific storage, dispensing, and compliance requirements. The resolution emphasizes the importance of timely medical treatment for pregnancy-related emergencies and seeks to ensure clarity and consistency in the application of these laws to protect patient safety.

The resolution outlines specific areas for the Department of Health to assess, including current practices for medication storage and access, barriers to timely care, and the impact of existing regulations on healthcare providers' ability to act in good faith. It also calls for stakeholder input through public meetings and a review of relevant medical research and public health data. The Department is tasked with preparing a written report detailing its findings and recommendations, which must be submitted to the House and Senate committees on health and welfare by February 1, 2027. The resolution clarifies that it does not intend to amend existing laws but aims to enhance their implementation for improved patient safety.